Trial Profile
Study to Show Non-inferiority of Tritanrix-HepB/Hib-MenAC (+/- Hepatitis B Vaccine at Birth) vs Tritanrix-HepB/Hiberix Without Hepatitis B Vacc. at Birth for Antibody Response to All Vaccine Antigens Given in Healthy Infants
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Jul 2022
Price :
$35
*
At a glance
- Drugs Hib-DTP-hepatitis B-meningococcal vaccine groups A and C conjugate (Primary) ; Hepatitis B vaccine; Hib-DTP hepatitis B vaccine (Tritanrix-HepB/Hiberix)
- Indications Diphtheria; Haemophilus infections; Hepatitis B; Meningococcal group A infections; Meningococcal group C infections; Meningococcal infections; Pertussis; Tetanus
- Focus Pharmacodynamics; Registrational
- Sponsors GlaxoSmithKline; GSK
- 14 Oct 2008 New trial record.